Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Markets & Finance

Robbie Stephens Cuts Regenegration Technology Rating


Robertson Stephens downgraded Regeneration Technology (RTIX) to outperform from buy.

Analyst Matt Duncan says he believes current accounting issues surrounding the company are associated with how inventory is charged to the cost of goods sold. He notes management has given no guidance regarding restatements or inventory write-downs.

Duncan says his best guess is to cut his $0.12 2001 EPS estimate to a $0.20 loss, and cut the $0.50 2002 EPS to $0.20 EPS. Duncan expects near-term uncertainty surrounding inventory adjustments to negatively affect the stock. He cut his $22 12-month target to $11.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus